NEW YORK (360Dx) – A urine-based diagnostic test for kidney transplant rejection provides new options for nephrologists who normally need to do tissue biopsies that are painful for patients, according to its maker.

The Numares renalTX-Score test employs four biomarkers — alanine, citrate, lactate, and urea — and eliminates the need for a tissue biopsy on patients, the firm, Numares, said.

Individually they are “mediocre biomarkers,” but taken in tandem they provide a robust evaluation of the risk for kidney rejection, Numares CTO Maximilian Zucker said in an interview.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.